Cybin Inc - Asset Resilience Ratio

Latest as of December 2022: 0.21%

Cybin Inc (CYBN) has an Asset Resilience Ratio of 0.21% as of December 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Cybin Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CA$125.00K

≈ $90.42K USD Cash + Short-term Investments

Total Assets

CA$60.69 Million

≈ $43.91 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Cybin Inc's Asset Resilience Ratio has changed over time. See net asset quality index of Cybin Inc to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Cybin Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Cybin Inc worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CA$0.00	0%
Short-term Investments	CA$125.00K	0.21%
Total Liquid Assets	CA$125.00K	0.21%

Asset Resilience Insights

Limited Liquidity: Cybin Inc maintains only 0.21% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Cybin Inc Industry Peers by Asset Resilience Ratio

Compare Cybin Inc's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Cyclacel Pharmaceuticals Inc NASDAQ:CYCC	Biotechnology	-55.36%
Krystal Biotech Inc NASDAQ:KRYS	Biotechnology	23.06%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
BB Biotech AG SW:BION	Biotechnology	0.05%

Annual Asset Resilience Ratio for Cybin Inc (None–None)

The table below shows the annual Asset Resilience Ratio data for Cybin Inc.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Cybin Inc

NEO:CYBN Canada Biotechnology

Market Cap

$301.37 Million

CA$416.62 Million CAD

Market Cap Rank

#14911 Global

#444 in Canada

Share Price

CA$8.35

Change (1 day)

-27.89%

52-Week Range

CA$7.70 - CA$11.99

All Time High

CA$150.86